{"id":"W4412480006","doi":"10.1016/j.annonc.2025.05.470","title":"454P Global physician and patient-reported symptom concordance in association with quality of life in HER2-negative advanced gastric, gastroesophageal or esophageal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"Servier; Deutsche Krebshilfe; Astellas Pharma; Eisai; Incyte; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; Gilead Sciences; Ipsen; BeiGene; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre","keywords":"Medicine; Concordance; Esophageal adenocarcinoma; Internal medicine; Gastroesophageal Junction; Gastroenterology; Quality of life (healthcare); Adenocarcinoma; Oncology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007833805,0.0002010245,0.000281305,0.0007494268,0.0002500773,0.000826258,0.0002711665,0.0004217282,0.003372933],"category_scores_gemma":[0.005541597,0.0001109192,0.000670096,0.00110008,0.0002725971,0.0004124139,0.0006517814,0.0005396578,0.000258141],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002745177,"about_ca_system_score_gemma":0.0002699289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002712957,"about_ca_topic_score_gemma":0.003557061,"domain_scores_codex":[0.9994659,0.0001887286,0.00007267509,0.00006835486,0.0001086144,0.00009566025],"domain_scores_gemma":[0.9966316,0.0009662806,0.001569155,0.0001133928,0.0002633704,0.0004561991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005574101,0.00001244064,0.999139,0.000007084343,0.00006056362,0.00002964236,0.00002931913,0.00003446779,0.00004469908,0.000007122917,0.00005211061,0.0005277916],"study_design_scores_gemma":[0.000002873855,0.00003770598,0.9993927,0.000003995454,0.00002554253,0.00009082017,0.0001288802,0.0001896096,0.00002307835,0.00001897052,0.00008342771,0.000002319117],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997718,0.0002580576,0.00005542861,0.0001090655,0.00001428288,0.000004708435,0.0006798338,0.000005001179,0.001155772],"genre_scores_gemma":[0.9994102,0.00004212995,0.00004567828,0.00002232773,0.00001165331,0.000002913678,0.000349596,0.000001542514,0.0001140609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003372933,"threshold_uncertainty_score":0.01128358,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0336975898894371,"score_gpt":0.3611031716158061,"score_spread":0.327405581726369,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}